R.Yu. ILINA¹, E.V. URAKOVA¹, O.V. NESTEROV¹, R.V. LEKSIN²

 ¹Kazan State Medical Academy — Branch Campus of  RMACPE MH Russia, Kazan

²Republican Clinical Hospital of the Ministry of Healthcare of the Republic of Tatarstan, Kazan

  Contact details:

Ilina R.Yu. — PhD (medicine), Associate Professor of the Department of Maxillofacial Surgery and Surgical Dentistry

Address: 36 Butlerova St., Kazan, Russian Federation, 420012, ​​tel. +7-917-255-43-87, e-mail: ilroza@yandex.ru

 This article describes a clinical case of Neurofibromatosis type 1 (NF1) (von Recklinghausen’s disease) in a patient with localization of formations in the maxillofacial region. Neurofibromatous nodes were located along the course of the second trigeminal branch — infraorbital; and the regional branch of the facial nerve. The patient was disturbed by radiating pain in the maxillofacial region. During surgical intervention, large nodes were removed, the diagnosis of neurofibromatosis was confirmed, and the pain syndrome was stopped.

Neurofibromatosis 1 (NF1) is a rare pathology encountered by maxillofacial surgeons, which causes difficulties in the initial diagnosis when visiting a dentist. 

Key words: Neurofibromatosis type 1 (NF1), von Recklinghausen’s disease, maxillofacial region.

(For citation: Ilina R.Yu., Urakova E.V., Nesterov O.V., Leksin R.V. A clinical case of Neurofibromatosis type 1 (NF1), also known as von Recklinghausen’s disease. Practical medicine. 2019, Vol. 17, № 6 (part 2), P. 64-66)

REFERENCES

1. Shnayder N.A., Gorelov A.I. Neurofibromatosis of the first type (Recklinghausen’s disease). Sibirskoe meditsinskoe obozrenie, no. 3, 2007, pp. 22-28 (in Russ.).
2. Liebermann F., Korf B.R. Emerging approaches toward the treatment of neurofibromatosis. Genet. Med, 1999, vol. 1, pp. 158-164.
3. Zhu Y., Parada L.F. Neurofibromin, a tumor suppressor in the nervous system. Exp. Cell Res, 2001, vol. 264, pp. 19-28.
4. Ruggieri M. The different forms of neurofibromatosis. Childs Nerv. Syst., 1999, vol. 15, pp. 295-308.
5. Rasmussen S.A., Yang Q., Friedman J.M. Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. Am. J. Hum. Genet, 2001, vol. 68, pp. 1110-1118.
6. Friedrich RE, Scheuer HT. Non-odontogenic Intraosseous Radiolucent Lesions of the Mandibular Body Are Rare Findings on Panoramic Views of Patients With Neurofibromatosis Type 1 / Anticancer Res, 2019, no. 39(4), pp. 1971-1985.
7. Tateishi A., Okada M., Nakai M., Yokota Y., Miyamoto Y. Spontaneous ascending aortic rupture in a pregnant woman with neurofibromatosis type 1. Gen Thorac Cardiovasc Surg, 2018, no. 17, pp. 122-128.
8. Leppävirta J., Kallionpää RA., Uusitalo E., Vahlberg T. Congenital anomalies in neurofibromatosis 1: a retrospective register-based total population study. Orphanet J Rare Dis, 2018, no. 13(1), pp. 5-16.